Predictors of Loss of Virologic Response in Subjects Who Simplified to Lopinavir/Ritonavir Monotherapy from Lopinavir/Ritonavir Plus Zidovudine/LamivudineCAMPO, Rafael E; DA SILVA, Barbara A; COTTE, Laurent et al.AIDS research and human retroviruses. 2009, Vol 25, Num 3, pp 269-275, issn 0889-2229, 7 p.Article

Comparison of Once-Daily Fosamprenavir Boosted with Either 100 or 200 mg of Ritonavir, in Combination with Abacavir/Lamivudine : 96-Week Results from COL100758HICKS, Charles B; DEJESUS, Edwin; SLOAN, Louis M et al.AIDS research and human retroviruses. 2009, Vol 25, Num 4, pp 395-403, issn 0889-2229, 9 p.Article

Lack of Minority K65R-Resistant Viral Populations Detected After Repeated Treatment Interruptions of Tenofovir/Zidovudine and Lamivudine in a Resource-Limited SettingMCCORMICK, Adele L; GOODALL, Ruth L; JOYCE, Aengus et al.Journal of acquired immune deficiency syndromes (1999). 2010, Vol 54, Num 2, pp 215-217, issn 1525-4135, 3 p.Article

Quantitative determination and sampling of lamivudine and zidovudine residues for cleaning validation in a production areaROCHA MIRITELLO SANTORO, Maria Inês; FAZIO, Tatiana Tatit; ANIL KUMAR SINGH et al.Journal of AOAC International. 2007, Vol 90, Num 3, pp 715-719, issn 1060-3271, 5 p.Article

Pharmacokinetic profiling and bioequivalence evaluation of 2 lamivudine tablet formulations after single oral administration in healthy human Indian volunteersNARANG, Vishal S; LULLA, Amar; MALHOTRA, Geena et al.Journal of acquired immune deficiency syndromes (1999). 2005, Vol 38, Num 5, pp 566-569, issn 1525-4135, 4 p.Article

Prior Therapy Influences the Efficacy of Lamivudine Monotherapy in Patients with Lamivudine-resistant HIV-1 InfectionOPRAVIL, Milos; KLIMKAIT, Thomas; LOUVEL, Severine et al.Journal of acquired immune deficiency syndromes (1999). 2010, Vol 54, Num 1, pp 51-58, issn 1525-4135, 8 p.Article

In vitro study of the effects of precore and lamivudine-resistant mutations on hepatitis B virus replicationHEIPERTZ, Richard A; MILLER, Thomas G; KELLEY, Colleen M et al.Journal of virology. 2007, Vol 81, Num 7, pp 3068-3076, issn 0022-538X, 9 p.Article

Virologic response of zidovudine, lamivudine, and tenofovir disoproxil fumarate combination in antiretroviral-naive HIV-1-infected patientsREY, David; KREBS, Magali; PARTISANI, Marialuisa et al.Journal of acquired immune deficiency syndromes (1999). 2006, Vol 43, Num 5, pp 530-534, issn 1525-4135, 5 p.Article

Spontaneous recovery of hemoglobin and neutrophil levels in Japanese patients on a long-term Combivir® containing regimenMATSUSHITA, Shuzo; YOSHIMURA, Kazuhisa; KIMURA, Tetsuya et al.Journal of clinical virology. 2005, Vol 33, Num 3, pp 188-193, issn 1386-6532, 6 p.Article

Tenofovir Disoproxil Fumarate, Emtricitabine, and Efavirenz Compared With Zidovudine/Lamivudine and Efavirenz in Treatment-Naive Patients : 144-Week AnalysisARRIBAS, Jose R; POZNIAK, Anton L; TOOLE, John J et al.Journal of acquired immune deficiency syndromes (1999). 2008, Vol 47, Num 1, pp 74-78, issn 1525-4135, 5 p.Article

The effects of prolonged treatment with zidovudine, lamivudine, and abacavir on a T-lymphoblastoid cell lineTURRIZIANI, Ombretta; PAGNOTTI, Paolo; PIERANGELI, Alessandra et al.AIDS research and human retroviruses. 2006, Vol 22, Num 10, pp 960-967, issn 0889-2229, 8 p.Article

A proof-of-concept study of short-cycle intermittent antiretroviral therapy with a once-daily regimen of didanosine, lamivudine, and efavirenz for the treatment of chronic HIV infectionDYBUL, Mark; NIES-KRASKE, Elizabeth; METCALF, Julia A et al.The Journal of infectious diseases. 2004, Vol 189, Num 11, pp 1974-1982, issn 0022-1899, 9 p.Article

Pyrosequencing for detection of lamivudine-resistant hepatitis B virusLINDSTRÖM, Anna; ODEBERG, Jacob; ALBERT, Jan et al.Journal of clinical microbiology (Print). 2004, Vol 42, Num 10, pp 4788-4795, issn 0095-1137, 8 p.Article

Efficacy and Safety of Unboosted Atazanavir in Combination with Lamivudine and Didanosine in Naive HIV Type 1 Patients in SenegalLANDMAN, R; DIALLO, M. B; GIRARD, P. M et al.AIDS research and human retroviruses. 2010, Vol 26, Num 5, pp 519-525, issn 0889-2229, 7 p.Article

Dynamics of hepatitis B virus resistance to lamivudinePALLIER, Coralie; CASTERA, Laurent; SOULIER, Alexandre et al.Journal of virology. 2006, Vol 80, Num 2, pp 643-653, issn 0022-538X, 11 p.Article

Differential impact of thymidine analogue mutations on emtricitabine and lamivudine susceptibilityROSS, Lisa L; PARKIN, Neil; GERONDELIS, Peter et al.Journal of acquired immune deficiency syndromes (1999). 2006, Vol 43, Num 5, pp 567-570, issn 1525-4135, 4 p.Article

Intracellular pharmacokinetics of tenofovir diphosphate, carbovir triphosphate, and lamivudine triphosphate in patients receiving triple-nucleoside regimensHAWKINS, Trevor; VEIKLEY, Wenoah; CLAIRE, Robert L. St. III et al.Journal of acquired immune deficiency syndromes (1999). 2005, Vol 39, Num 4, pp 406-411, issn 1525-4135, 6 p.Article

Prospective randomized trial of emtricitabine versus lamivudine short-term monotherapy in human immunodeficiency virus-infected patientsROUSSEAU, Franck S; WAKEFORD, Charles; MOMMELA-MARIN, Herve et al.The Journal of infectious diseases. 2003, Vol 188, Num 11, pp 1652-1658, issn 0022-1899, 7 p.Article

Dual therapy with lopinavir and ritonavir plus lamivudine versus triple therapy with lopinavir and ritonavir plus two nucleoside reverse transcriptase inhibitors in antiretroviral-therapy-naive adults with HIV-1 infection: 48 week results of the randomised, open label, non-inferiority GARDEL trialCAHN, Pedro; ANDRADE-VILLANUEVA, Jaime; ROLON, Maria José et al.Lancet. Infectious diseases (print). 2014, Vol 14, Num 7, pp 572-580, issn 1473-3099, 9 p.Article

Pretreatment HBsAg level and an early decrease in MELD score predict prognosis to lamivudine treatment for HBeAg-negative acute-on-chronic liver failureJING LAI; LIN, Chao-Shuang; LIN YANG et al.Clinics and research in hepatology and gastroenterology (Print). 2014, Vol 38, Num 3, pp 331-336, issn 2210-7401, 6 p.Article

Safety analysis of Epzicom® (lamivudine/abacavir sulfate) in post-marketing surveillance in JapanKURITA, Tomoko; KITAICHI, Tomomi; NAGAO, Takako et al.Pharmacoepidemiology and drug safety. 2014, Vol 23, Num 4, pp 372-381, issn 1053-8569, 10 p.Article

Different mechanism of selection of adefovir-resistant mutant viruses during adefovir monotherapy in patients with lamivudine-resistant chronic hepatitis BCHO, Yoo-Kyung; CUI, Xiu-Ji; SEUNG UK JEONG et al.Antiviral research. 2014, Vol 112, pp 8-17, issn 0166-3542, 10 p.Article

Dolutegravir plus Abacavir―Lamivudine for the Treatment of HIV-1 InfectionWALMSLEY, Sharon L; ANTELA, Antonio; PAPPA, Keith et al.The New England journal of medicine. 2013, Vol 369, Num 19, pp 1807-1818, issn 0028-4793, 12 p.Article

High Frequency of Complex Mutational Patterns in Lamivudine Resistant Hepatitis B Virus IsolatesNEUMANN-FRAUNE, Maria; BEGGEL, Bastian; PFISTER, Herbert et al.Journal of medical virology. 2013, Vol 85, Num 5, pp 775-779, issn 0146-6615, 5 p.Article

Pharmacokinetic Properties of Single-Dose Lamivudine/Adefovir Dipivoxil Fixed-Dose Combination in Healthy Chinese Male VolunteersFOK, Benny S. P; GARDNER, Stephen; PISCITELLI, Steve et al.Clinical therapeutics. 2013, Vol 35, Num 1, pp 68-76, issn 0149-2918, 9 p.Article